6月4日，美敦力盘中上涨3.63%，报82.03美元/股，成交额1.72亿美元。公司延续前一交易日财报发布后的强势表现。
消息面上，美敦力此前公布第四财季及全年业绩，实现过去十年最强劲年度营收增长。第四财季销售额98.07亿美元，超出市场预期的96.35亿美元；核心心血管业务受脉冲场消融产品组合旺盛需求推动，同比大幅增长13.8%。此外，BTIG将美敦力评级从中性上调至买入，目标价90美元，进一步提振市场情绪。
同日，公司宣布已向FDA提交510(K)申请，拟将Hugo机器人辅助手术系统适应症拓展至普外科及妇科领域，并战略投资两家心内超声导管公司以支持心脏消融产品组合扩张，多重催化因素叠加推动股价持续走强。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.